Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin Supplementation in Metabolic Syndrome
NCT01038921Phase 2Completed
- Sponsor
- Emory University
- Start
- Jul 2009
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in metabolic syndrome, sponsored by Emory University. Started Jul 2009; status: completed.
02
Drugs
melatonin
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT01038921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01038921.